Global Therapeutic Antibodies Drug Market Research Report 2024(Status and Outlook)
Report Overview
Therapeutic antibodies are drugs that use antibodies, one of the main players in our immune system inherent in our body. By making use of the specificity by which each antibody recognizes only one antigen, pinpointed attacks on specific antigens are possible.
The global Therapeutic Antibodies Drug market size was estimated at USD 175410 million in 2023 and is projected to reach USD 364179.25 million by 2030, exhibiting a CAGR of 11.00% during the forecast period.
North America Therapeutic Antibodies Drug market size was USD 45706.83 million in 2023, at a CAGR of 9.43% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Therapeutic Antibodies Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Therapeutic Antibodies Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Therapeutic Antibodies Drug market in any manner.
Global Therapeutic Antibodies Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
Regeneron
Innovent
Hengrui Medicine
Market Segmentation (by Type)
Monoclonal Antibodies
Bi-Specific Antibodies Therapy
Antibody-drug Conjugates
Other
Market Segmentation (by Application)
Immune Diseases
Cancer
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Antibodies Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
Therapeutic antibodies are drugs that use antibodies, one of the main players in our immune system inherent in our body. By making use of the specificity by which each antibody recognizes only one antigen, pinpointed attacks on specific antigens are possible.
The global Therapeutic Antibodies Drug market size was estimated at USD 175410 million in 2023 and is projected to reach USD 364179.25 million by 2030, exhibiting a CAGR of 11.00% during the forecast period.
North America Therapeutic Antibodies Drug market size was USD 45706.83 million in 2023, at a CAGR of 9.43% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Therapeutic Antibodies Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Therapeutic Antibodies Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Therapeutic Antibodies Drug market in any manner.
Global Therapeutic Antibodies Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
Regeneron
Innovent
Hengrui Medicine
Market Segmentation (by Type)
Monoclonal Antibodies
Bi-Specific Antibodies Therapy
Antibody-drug Conjugates
Other
Market Segmentation (by Application)
Immune Diseases
Cancer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Therapeutic Antibodies Drug Market
- Overview of the regional outlook of the Therapeutic Antibodies Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Antibodies Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Therapeutic Antibodies Drug
1.2 Key Market Segments
1.2.1 Therapeutic Antibodies Drug Segment by Type
1.2.2 Therapeutic Antibodies Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 THERAPEUTIC ANTIBODIES DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Therapeutic Antibodies Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Therapeutic Antibodies Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 THERAPEUTIC ANTIBODIES DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Therapeutic Antibodies Drug Sales by Manufacturers (2019-2024)
3.2 Global Therapeutic Antibodies Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Therapeutic Antibodies Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Therapeutic Antibodies Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Therapeutic Antibodies Drug Sales Sites, Area Served, Product Type
3.6 Therapeutic Antibodies Drug Market Competitive Situation and Trends
3.6.1 Therapeutic Antibodies Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Therapeutic Antibodies Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 THERAPEUTIC ANTIBODIES DRUG INDUSTRY CHAIN ANALYSIS
4.1 Therapeutic Antibodies Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF THERAPEUTIC ANTIBODIES DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 THERAPEUTIC ANTIBODIES DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Antibodies Drug Sales Market Share by Type (2019-2024)
6.3 Global Therapeutic Antibodies Drug Market Size Market Share by Type (2019-2024)
6.4 Global Therapeutic Antibodies Drug Price by Type (2019-2024)
7 THERAPEUTIC ANTIBODIES DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Antibodies Drug Market Sales by Application (2019-2024)
7.3 Global Therapeutic Antibodies Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Therapeutic Antibodies Drug Sales Growth Rate by Application (2019-2024)
8 THERAPEUTIC ANTIBODIES DRUG MARKET SEGMENTATION BY REGION
8.1 Global Therapeutic Antibodies Drug Sales by Region
8.1.1 Global Therapeutic Antibodies Drug Sales by Region
8.1.2 Global Therapeutic Antibodies Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Therapeutic Antibodies Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Therapeutic Antibodies Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Therapeutic Antibodies Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Therapeutic Antibodies Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Therapeutic Antibodies Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AbbVie
9.1.1 AbbVie Therapeutic Antibodies Drug Basic Information
9.1.2 AbbVie Therapeutic Antibodies Drug Product Overview
9.1.3 AbbVie Therapeutic Antibodies Drug Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Therapeutic Antibodies Drug SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Therapeutic Antibodies Drug Basic Information
9.2.2 Johnson and Johnson Therapeutic Antibodies Drug Product Overview
9.2.3 Johnson and Johnson Therapeutic Antibodies Drug Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Therapeutic Antibodies Drug SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 Novartis
9.3.1 Novartis Therapeutic Antibodies Drug Basic Information
9.3.2 Novartis Therapeutic Antibodies Drug Product Overview
9.3.3 Novartis Therapeutic Antibodies Drug Product Market Performance
9.3.4 Novartis Therapeutic Antibodies Drug SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Gilead Sciences
9.4.1 Gilead Sciences Therapeutic Antibodies Drug Basic Information
9.4.2 Gilead Sciences Therapeutic Antibodies Drug Product Overview
9.4.3 Gilead Sciences Therapeutic Antibodies Drug Product Market Performance
9.4.4 Gilead Sciences Business Overview
9.4.5 Gilead Sciences Recent Developments
9.5 Roche
9.5.1 Roche Therapeutic Antibodies Drug Basic Information
9.5.2 Roche Therapeutic Antibodies Drug Product Overview
9.5.3 Roche Therapeutic Antibodies Drug Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Bristol-Myers Squibb
9.6.1 Bristol-Myers Squibb Therapeutic Antibodies Drug Basic Information
9.6.2 Bristol-Myers Squibb Therapeutic Antibodies Drug Product Overview
9.6.3 Bristol-Myers Squibb Therapeutic Antibodies Drug Product Market Performance
9.6.4 Bristol-Myers Squibb Business Overview
9.6.5 Bristol-Myers Squibb Recent Developments
9.7 Amgen
9.7.1 Amgen Therapeutic Antibodies Drug Basic Information
9.7.2 Amgen Therapeutic Antibodies Drug Product Overview
9.7.3 Amgen Therapeutic Antibodies Drug Product Market Performance
9.7.4 Amgen Business Overview
9.7.5 Amgen Recent Developments
9.8 AstraZeneca
9.8.1 AstraZeneca Therapeutic Antibodies Drug Basic Information
9.8.2 AstraZeneca Therapeutic Antibodies Drug Product Overview
9.8.3 AstraZeneca Therapeutic Antibodies Drug Product Market Performance
9.8.4 AstraZeneca Business Overview
9.8.5 AstraZeneca Recent Developments
9.9 Merck and Co
9.9.1 Merck and Co Therapeutic Antibodies Drug Basic Information
9.9.2 Merck and Co Therapeutic Antibodies Drug Product Overview
9.9.3 Merck and Co Therapeutic Antibodies Drug Product Market Performance
9.9.4 Merck and Co Business Overview
9.9.5 Merck and Co Recent Developments
9.10 Takeda
9.10.1 Takeda Therapeutic Antibodies Drug Basic Information
9.10.2 Takeda Therapeutic Antibodies Drug Product Overview
9.10.3 Takeda Therapeutic Antibodies Drug Product Market Performance
9.10.4 Takeda Business Overview
9.10.5 Takeda Recent Developments
9.11 Merck KGaA
9.11.1 Merck KGaA Therapeutic Antibodies Drug Basic Information
9.11.2 Merck KGaA Therapeutic Antibodies Drug Product Overview
9.11.3 Merck KGaA Therapeutic Antibodies Drug Product Market Performance
9.11.4 Merck KGaA Business Overview
9.11.5 Merck KGaA Recent Developments
9.12 Seagen
9.12.1 Seagen Therapeutic Antibodies Drug Basic Information
9.12.2 Seagen Therapeutic Antibodies Drug Product Overview
9.12.3 Seagen Therapeutic Antibodies Drug Product Market Performance
9.12.4 Seagen Business Overview
9.12.5 Seagen Recent Developments
9.13 Eli Lilly
9.13.1 Eli Lilly Therapeutic Antibodies Drug Basic Information
9.13.2 Eli Lilly Therapeutic Antibodies Drug Product Overview
9.13.3 Eli Lilly Therapeutic Antibodies Drug Product Market Performance
9.13.4 Eli Lilly Business Overview
9.13.5 Eli Lilly Recent Developments
9.14 Ono Pharmaceutical
9.14.1 Ono Pharmaceutical Therapeutic Antibodies Drug Basic Information
9.14.2 Ono Pharmaceutical Therapeutic Antibodies Drug Product Overview
9.14.3 Ono Pharmaceutical Therapeutic Antibodies Drug Product Market Performance
9.14.4 Ono Pharmaceutical Business Overview
9.14.5 Ono Pharmaceutical Recent Developments
9.15 Pfizer
9.15.1 Pfizer Therapeutic Antibodies Drug Basic Information
9.15.2 Pfizer Therapeutic Antibodies Drug Product Overview
9.15.3 Pfizer Therapeutic Antibodies Drug Product Market Performance
9.15.4 Pfizer Business Overview
9.15.5 Pfizer Recent Developments
9.16 Regeneron
9.16.1 Regeneron Therapeutic Antibodies Drug Basic Information
9.16.2 Regeneron Therapeutic Antibodies Drug Product Overview
9.16.3 Regeneron Therapeutic Antibodies Drug Product Market Performance
9.16.4 Regeneron Business Overview
9.16.5 Regeneron Recent Developments
9.17 Innovent
9.17.1 Innovent Therapeutic Antibodies Drug Basic Information
9.17.2 Innovent Therapeutic Antibodies Drug Product Overview
9.17.3 Innovent Therapeutic Antibodies Drug Product Market Performance
9.17.4 Innovent Business Overview
9.17.5 Innovent Recent Developments
9.18 Hengrui Medicine
9.18.1 Hengrui Medicine Therapeutic Antibodies Drug Basic Information
9.18.2 Hengrui Medicine Therapeutic Antibodies Drug Product Overview
9.18.3 Hengrui Medicine Therapeutic Antibodies Drug Product Market Performance
9.18.4 Hengrui Medicine Business Overview
9.18.5 Hengrui Medicine Recent Developments
10 THERAPEUTIC ANTIBODIES DRUG MARKET FORECAST BY REGION
10.1 Global Therapeutic Antibodies Drug Market Size Forecast
10.2 Global Therapeutic Antibodies Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Therapeutic Antibodies Drug Market Size Forecast by Country
10.2.3 Asia Pacific Therapeutic Antibodies Drug Market Size Forecast by Region
10.2.4 South America Therapeutic Antibodies Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Therapeutic Antibodies Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Therapeutic Antibodies Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Therapeutic Antibodies Drug by Type (2025-2030)
11.1.2 Global Therapeutic Antibodies Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Therapeutic Antibodies Drug by Type (2025-2030)
11.2 Global Therapeutic Antibodies Drug Market Forecast by Application (2025-2030)
11.2.1 Global Therapeutic Antibodies Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Therapeutic Antibodies Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Therapeutic Antibodies Drug
1.2 Key Market Segments
1.2.1 Therapeutic Antibodies Drug Segment by Type
1.2.2 Therapeutic Antibodies Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 THERAPEUTIC ANTIBODIES DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Therapeutic Antibodies Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Therapeutic Antibodies Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 THERAPEUTIC ANTIBODIES DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Therapeutic Antibodies Drug Sales by Manufacturers (2019-2024)
3.2 Global Therapeutic Antibodies Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Therapeutic Antibodies Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Therapeutic Antibodies Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Therapeutic Antibodies Drug Sales Sites, Area Served, Product Type
3.6 Therapeutic Antibodies Drug Market Competitive Situation and Trends
3.6.1 Therapeutic Antibodies Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Therapeutic Antibodies Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 THERAPEUTIC ANTIBODIES DRUG INDUSTRY CHAIN ANALYSIS
4.1 Therapeutic Antibodies Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF THERAPEUTIC ANTIBODIES DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 THERAPEUTIC ANTIBODIES DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Antibodies Drug Sales Market Share by Type (2019-2024)
6.3 Global Therapeutic Antibodies Drug Market Size Market Share by Type (2019-2024)
6.4 Global Therapeutic Antibodies Drug Price by Type (2019-2024)
7 THERAPEUTIC ANTIBODIES DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Antibodies Drug Market Sales by Application (2019-2024)
7.3 Global Therapeutic Antibodies Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Therapeutic Antibodies Drug Sales Growth Rate by Application (2019-2024)
8 THERAPEUTIC ANTIBODIES DRUG MARKET SEGMENTATION BY REGION
8.1 Global Therapeutic Antibodies Drug Sales by Region
8.1.1 Global Therapeutic Antibodies Drug Sales by Region
8.1.2 Global Therapeutic Antibodies Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Therapeutic Antibodies Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Therapeutic Antibodies Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Therapeutic Antibodies Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Therapeutic Antibodies Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Therapeutic Antibodies Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AbbVie
9.1.1 AbbVie Therapeutic Antibodies Drug Basic Information
9.1.2 AbbVie Therapeutic Antibodies Drug Product Overview
9.1.3 AbbVie Therapeutic Antibodies Drug Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Therapeutic Antibodies Drug SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Therapeutic Antibodies Drug Basic Information
9.2.2 Johnson and Johnson Therapeutic Antibodies Drug Product Overview
9.2.3 Johnson and Johnson Therapeutic Antibodies Drug Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Therapeutic Antibodies Drug SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 Novartis
9.3.1 Novartis Therapeutic Antibodies Drug Basic Information
9.3.2 Novartis Therapeutic Antibodies Drug Product Overview
9.3.3 Novartis Therapeutic Antibodies Drug Product Market Performance
9.3.4 Novartis Therapeutic Antibodies Drug SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Gilead Sciences
9.4.1 Gilead Sciences Therapeutic Antibodies Drug Basic Information
9.4.2 Gilead Sciences Therapeutic Antibodies Drug Product Overview
9.4.3 Gilead Sciences Therapeutic Antibodies Drug Product Market Performance
9.4.4 Gilead Sciences Business Overview
9.4.5 Gilead Sciences Recent Developments
9.5 Roche
9.5.1 Roche Therapeutic Antibodies Drug Basic Information
9.5.2 Roche Therapeutic Antibodies Drug Product Overview
9.5.3 Roche Therapeutic Antibodies Drug Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Bristol-Myers Squibb
9.6.1 Bristol-Myers Squibb Therapeutic Antibodies Drug Basic Information
9.6.2 Bristol-Myers Squibb Therapeutic Antibodies Drug Product Overview
9.6.3 Bristol-Myers Squibb Therapeutic Antibodies Drug Product Market Performance
9.6.4 Bristol-Myers Squibb Business Overview
9.6.5 Bristol-Myers Squibb Recent Developments
9.7 Amgen
9.7.1 Amgen Therapeutic Antibodies Drug Basic Information
9.7.2 Amgen Therapeutic Antibodies Drug Product Overview
9.7.3 Amgen Therapeutic Antibodies Drug Product Market Performance
9.7.4 Amgen Business Overview
9.7.5 Amgen Recent Developments
9.8 AstraZeneca
9.8.1 AstraZeneca Therapeutic Antibodies Drug Basic Information
9.8.2 AstraZeneca Therapeutic Antibodies Drug Product Overview
9.8.3 AstraZeneca Therapeutic Antibodies Drug Product Market Performance
9.8.4 AstraZeneca Business Overview
9.8.5 AstraZeneca Recent Developments
9.9 Merck and Co
9.9.1 Merck and Co Therapeutic Antibodies Drug Basic Information
9.9.2 Merck and Co Therapeutic Antibodies Drug Product Overview
9.9.3 Merck and Co Therapeutic Antibodies Drug Product Market Performance
9.9.4 Merck and Co Business Overview
9.9.5 Merck and Co Recent Developments
9.10 Takeda
9.10.1 Takeda Therapeutic Antibodies Drug Basic Information
9.10.2 Takeda Therapeutic Antibodies Drug Product Overview
9.10.3 Takeda Therapeutic Antibodies Drug Product Market Performance
9.10.4 Takeda Business Overview
9.10.5 Takeda Recent Developments
9.11 Merck KGaA
9.11.1 Merck KGaA Therapeutic Antibodies Drug Basic Information
9.11.2 Merck KGaA Therapeutic Antibodies Drug Product Overview
9.11.3 Merck KGaA Therapeutic Antibodies Drug Product Market Performance
9.11.4 Merck KGaA Business Overview
9.11.5 Merck KGaA Recent Developments
9.12 Seagen
9.12.1 Seagen Therapeutic Antibodies Drug Basic Information
9.12.2 Seagen Therapeutic Antibodies Drug Product Overview
9.12.3 Seagen Therapeutic Antibodies Drug Product Market Performance
9.12.4 Seagen Business Overview
9.12.5 Seagen Recent Developments
9.13 Eli Lilly
9.13.1 Eli Lilly Therapeutic Antibodies Drug Basic Information
9.13.2 Eli Lilly Therapeutic Antibodies Drug Product Overview
9.13.3 Eli Lilly Therapeutic Antibodies Drug Product Market Performance
9.13.4 Eli Lilly Business Overview
9.13.5 Eli Lilly Recent Developments
9.14 Ono Pharmaceutical
9.14.1 Ono Pharmaceutical Therapeutic Antibodies Drug Basic Information
9.14.2 Ono Pharmaceutical Therapeutic Antibodies Drug Product Overview
9.14.3 Ono Pharmaceutical Therapeutic Antibodies Drug Product Market Performance
9.14.4 Ono Pharmaceutical Business Overview
9.14.5 Ono Pharmaceutical Recent Developments
9.15 Pfizer
9.15.1 Pfizer Therapeutic Antibodies Drug Basic Information
9.15.2 Pfizer Therapeutic Antibodies Drug Product Overview
9.15.3 Pfizer Therapeutic Antibodies Drug Product Market Performance
9.15.4 Pfizer Business Overview
9.15.5 Pfizer Recent Developments
9.16 Regeneron
9.16.1 Regeneron Therapeutic Antibodies Drug Basic Information
9.16.2 Regeneron Therapeutic Antibodies Drug Product Overview
9.16.3 Regeneron Therapeutic Antibodies Drug Product Market Performance
9.16.4 Regeneron Business Overview
9.16.5 Regeneron Recent Developments
9.17 Innovent
9.17.1 Innovent Therapeutic Antibodies Drug Basic Information
9.17.2 Innovent Therapeutic Antibodies Drug Product Overview
9.17.3 Innovent Therapeutic Antibodies Drug Product Market Performance
9.17.4 Innovent Business Overview
9.17.5 Innovent Recent Developments
9.18 Hengrui Medicine
9.18.1 Hengrui Medicine Therapeutic Antibodies Drug Basic Information
9.18.2 Hengrui Medicine Therapeutic Antibodies Drug Product Overview
9.18.3 Hengrui Medicine Therapeutic Antibodies Drug Product Market Performance
9.18.4 Hengrui Medicine Business Overview
9.18.5 Hengrui Medicine Recent Developments
10 THERAPEUTIC ANTIBODIES DRUG MARKET FORECAST BY REGION
10.1 Global Therapeutic Antibodies Drug Market Size Forecast
10.2 Global Therapeutic Antibodies Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Therapeutic Antibodies Drug Market Size Forecast by Country
10.2.3 Asia Pacific Therapeutic Antibodies Drug Market Size Forecast by Region
10.2.4 South America Therapeutic Antibodies Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Therapeutic Antibodies Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Therapeutic Antibodies Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Therapeutic Antibodies Drug by Type (2025-2030)
11.1.2 Global Therapeutic Antibodies Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Therapeutic Antibodies Drug by Type (2025-2030)
11.2 Global Therapeutic Antibodies Drug Market Forecast by Application (2025-2030)
11.2.1 Global Therapeutic Antibodies Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Therapeutic Antibodies Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Therapeutic Antibodies Drug Market Size Comparison by Region (M USD)
Table 5. Global Therapeutic Antibodies Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Therapeutic Antibodies Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Therapeutic Antibodies Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Therapeutic Antibodies Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Antibodies Drug as of 2022)
Table 10. Global Market Therapeutic Antibodies Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Therapeutic Antibodies Drug Sales Sites and Area Served
Table 12. Manufacturers Therapeutic Antibodies Drug Product Type
Table 13. Global Therapeutic Antibodies Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Therapeutic Antibodies Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Therapeutic Antibodies Drug Market Challenges
Table 22. Global Therapeutic Antibodies Drug Sales by Type (Kilotons)
Table 23. Global Therapeutic Antibodies Drug Market Size by Type (M USD)
Table 24. Global Therapeutic Antibodies Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Therapeutic Antibodies Drug Sales Market Share by Type (2019-2024)
Table 26. Global Therapeutic Antibodies Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Therapeutic Antibodies Drug Market Size Share by Type (2019-2024)
Table 28. Global Therapeutic Antibodies Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Therapeutic Antibodies Drug Sales (Kilotons) by Application
Table 30. Global Therapeutic Antibodies Drug Market Size by Application
Table 31. Global Therapeutic Antibodies Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Therapeutic Antibodies Drug Sales Market Share by Application (2019-2024)
Table 33. Global Therapeutic Antibodies Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Therapeutic Antibodies Drug Market Share by Application (2019-2024)
Table 35. Global Therapeutic Antibodies Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Therapeutic Antibodies Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Therapeutic Antibodies Drug Sales Market Share by Region (2019-2024)
Table 38. North America Therapeutic Antibodies Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Therapeutic Antibodies Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Therapeutic Antibodies Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Therapeutic Antibodies Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Therapeutic Antibodies Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. AbbVie Therapeutic Antibodies Drug Basic Information
Table 44. AbbVie Therapeutic Antibodies Drug Product Overview
Table 45. AbbVie Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AbbVie Business Overview
Table 47. AbbVie Therapeutic Antibodies Drug SWOT Analysis
Table 48. AbbVie Recent Developments
Table 49. Johnson and Johnson Therapeutic Antibodies Drug Basic Information
Table 50. Johnson and Johnson Therapeutic Antibodies Drug Product Overview
Table 51. Johnson and Johnson Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Johnson and Johnson Business Overview
Table 53. Johnson and Johnson Therapeutic Antibodies Drug SWOT Analysis
Table 54. Johnson and Johnson Recent Developments
Table 55. Novartis Therapeutic Antibodies Drug Basic Information
Table 56. Novartis Therapeutic Antibodies Drug Product Overview
Table 57. Novartis Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis Therapeutic Antibodies Drug SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Gilead Sciences Therapeutic Antibodies Drug Basic Information
Table 62. Gilead Sciences Therapeutic Antibodies Drug Product Overview
Table 63. Gilead Sciences Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Gilead Sciences Business Overview
Table 65. Gilead Sciences Recent Developments
Table 66. Roche Therapeutic Antibodies Drug Basic Information
Table 67. Roche Therapeutic Antibodies Drug Product Overview
Table 68. Roche Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. Bristol-Myers Squibb Therapeutic Antibodies Drug Basic Information
Table 72. Bristol-Myers Squibb Therapeutic Antibodies Drug Product Overview
Table 73. Bristol-Myers Squibb Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Recent Developments
Table 76. Amgen Therapeutic Antibodies Drug Basic Information
Table 77. Amgen Therapeutic Antibodies Drug Product Overview
Table 78. Amgen Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Amgen Business Overview
Table 80. Amgen Recent Developments
Table 81. AstraZeneca Therapeutic Antibodies Drug Basic Information
Table 82. AstraZeneca Therapeutic Antibodies Drug Product Overview
Table 83. AstraZeneca Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Recent Developments
Table 86. Merck and Co Therapeutic Antibodies Drug Basic Information
Table 87. Merck and Co Therapeutic Antibodies Drug Product Overview
Table 88. Merck and Co Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Merck and Co Business Overview
Table 90. Merck and Co Recent Developments
Table 91. Takeda Therapeutic Antibodies Drug Basic Information
Table 92. Takeda Therapeutic Antibodies Drug Product Overview
Table 93. Takeda Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Takeda Business Overview
Table 95. Takeda Recent Developments
Table 96. Merck KGaA Therapeutic Antibodies Drug Basic Information
Table 97. Merck KGaA Therapeutic Antibodies Drug Product Overview
Table 98. Merck KGaA Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Merck KGaA Business Overview
Table 100. Merck KGaA Recent Developments
Table 101. Seagen Therapeutic Antibodies Drug Basic Information
Table 102. Seagen Therapeutic Antibodies Drug Product Overview
Table 103. Seagen Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Seagen Business Overview
Table 105. Seagen Recent Developments
Table 106. Eli Lilly Therapeutic Antibodies Drug Basic Information
Table 107. Eli Lilly Therapeutic Antibodies Drug Product Overview
Table 108. Eli Lilly Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Recent Developments
Table 111. Ono Pharmaceutical Therapeutic Antibodies Drug Basic Information
Table 112. Ono Pharmaceutical Therapeutic Antibodies Drug Product Overview
Table 113. Ono Pharmaceutical Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Ono Pharmaceutical Business Overview
Table 115. Ono Pharmaceutical Recent Developments
Table 116. Pfizer Therapeutic Antibodies Drug Basic Information
Table 117. Pfizer Therapeutic Antibodies Drug Product Overview
Table 118. Pfizer Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Pfizer Business Overview
Table 120. Pfizer Recent Developments
Table 121. Regeneron Therapeutic Antibodies Drug Basic Information
Table 122. Regeneron Therapeutic Antibodies Drug Product Overview
Table 123. Regeneron Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Regeneron Business Overview
Table 125. Regeneron Recent Developments
Table 126. Innovent Therapeutic Antibodies Drug Basic Information
Table 127. Innovent Therapeutic Antibodies Drug Product Overview
Table 128. Innovent Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Innovent Business Overview
Table 130. Innovent Recent Developments
Table 131. Hengrui Medicine Therapeutic Antibodies Drug Basic Information
Table 132. Hengrui Medicine Therapeutic Antibodies Drug Product Overview
Table 133. Hengrui Medicine Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Hengrui Medicine Business Overview
Table 135. Hengrui Medicine Recent Developments
Table 136. Global Therapeutic Antibodies Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Therapeutic Antibodies Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Therapeutic Antibodies Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Therapeutic Antibodies Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Therapeutic Antibodies Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Therapeutic Antibodies Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Therapeutic Antibodies Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Therapeutic Antibodies Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Therapeutic Antibodies Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Therapeutic Antibodies Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Therapeutic Antibodies Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Therapeutic Antibodies Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Therapeutic Antibodies Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Therapeutic Antibodies Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Therapeutic Antibodies Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Therapeutic Antibodies Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Therapeutic Antibodies Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Therapeutic Antibodies Drug Market Size Comparison by Region (M USD)
Table 5. Global Therapeutic Antibodies Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Therapeutic Antibodies Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Therapeutic Antibodies Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Therapeutic Antibodies Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Antibodies Drug as of 2022)
Table 10. Global Market Therapeutic Antibodies Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Therapeutic Antibodies Drug Sales Sites and Area Served
Table 12. Manufacturers Therapeutic Antibodies Drug Product Type
Table 13. Global Therapeutic Antibodies Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Therapeutic Antibodies Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Therapeutic Antibodies Drug Market Challenges
Table 22. Global Therapeutic Antibodies Drug Sales by Type (Kilotons)
Table 23. Global Therapeutic Antibodies Drug Market Size by Type (M USD)
Table 24. Global Therapeutic Antibodies Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Therapeutic Antibodies Drug Sales Market Share by Type (2019-2024)
Table 26. Global Therapeutic Antibodies Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Therapeutic Antibodies Drug Market Size Share by Type (2019-2024)
Table 28. Global Therapeutic Antibodies Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Therapeutic Antibodies Drug Sales (Kilotons) by Application
Table 30. Global Therapeutic Antibodies Drug Market Size by Application
Table 31. Global Therapeutic Antibodies Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Therapeutic Antibodies Drug Sales Market Share by Application (2019-2024)
Table 33. Global Therapeutic Antibodies Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Therapeutic Antibodies Drug Market Share by Application (2019-2024)
Table 35. Global Therapeutic Antibodies Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Therapeutic Antibodies Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Therapeutic Antibodies Drug Sales Market Share by Region (2019-2024)
Table 38. North America Therapeutic Antibodies Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Therapeutic Antibodies Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Therapeutic Antibodies Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Therapeutic Antibodies Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Therapeutic Antibodies Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. AbbVie Therapeutic Antibodies Drug Basic Information
Table 44. AbbVie Therapeutic Antibodies Drug Product Overview
Table 45. AbbVie Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AbbVie Business Overview
Table 47. AbbVie Therapeutic Antibodies Drug SWOT Analysis
Table 48. AbbVie Recent Developments
Table 49. Johnson and Johnson Therapeutic Antibodies Drug Basic Information
Table 50. Johnson and Johnson Therapeutic Antibodies Drug Product Overview
Table 51. Johnson and Johnson Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Johnson and Johnson Business Overview
Table 53. Johnson and Johnson Therapeutic Antibodies Drug SWOT Analysis
Table 54. Johnson and Johnson Recent Developments
Table 55. Novartis Therapeutic Antibodies Drug Basic Information
Table 56. Novartis Therapeutic Antibodies Drug Product Overview
Table 57. Novartis Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis Therapeutic Antibodies Drug SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Gilead Sciences Therapeutic Antibodies Drug Basic Information
Table 62. Gilead Sciences Therapeutic Antibodies Drug Product Overview
Table 63. Gilead Sciences Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Gilead Sciences Business Overview
Table 65. Gilead Sciences Recent Developments
Table 66. Roche Therapeutic Antibodies Drug Basic Information
Table 67. Roche Therapeutic Antibodies Drug Product Overview
Table 68. Roche Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. Bristol-Myers Squibb Therapeutic Antibodies Drug Basic Information
Table 72. Bristol-Myers Squibb Therapeutic Antibodies Drug Product Overview
Table 73. Bristol-Myers Squibb Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Recent Developments
Table 76. Amgen Therapeutic Antibodies Drug Basic Information
Table 77. Amgen Therapeutic Antibodies Drug Product Overview
Table 78. Amgen Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Amgen Business Overview
Table 80. Amgen Recent Developments
Table 81. AstraZeneca Therapeutic Antibodies Drug Basic Information
Table 82. AstraZeneca Therapeutic Antibodies Drug Product Overview
Table 83. AstraZeneca Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Recent Developments
Table 86. Merck and Co Therapeutic Antibodies Drug Basic Information
Table 87. Merck and Co Therapeutic Antibodies Drug Product Overview
Table 88. Merck and Co Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Merck and Co Business Overview
Table 90. Merck and Co Recent Developments
Table 91. Takeda Therapeutic Antibodies Drug Basic Information
Table 92. Takeda Therapeutic Antibodies Drug Product Overview
Table 93. Takeda Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Takeda Business Overview
Table 95. Takeda Recent Developments
Table 96. Merck KGaA Therapeutic Antibodies Drug Basic Information
Table 97. Merck KGaA Therapeutic Antibodies Drug Product Overview
Table 98. Merck KGaA Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Merck KGaA Business Overview
Table 100. Merck KGaA Recent Developments
Table 101. Seagen Therapeutic Antibodies Drug Basic Information
Table 102. Seagen Therapeutic Antibodies Drug Product Overview
Table 103. Seagen Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Seagen Business Overview
Table 105. Seagen Recent Developments
Table 106. Eli Lilly Therapeutic Antibodies Drug Basic Information
Table 107. Eli Lilly Therapeutic Antibodies Drug Product Overview
Table 108. Eli Lilly Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Recent Developments
Table 111. Ono Pharmaceutical Therapeutic Antibodies Drug Basic Information
Table 112. Ono Pharmaceutical Therapeutic Antibodies Drug Product Overview
Table 113. Ono Pharmaceutical Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Ono Pharmaceutical Business Overview
Table 115. Ono Pharmaceutical Recent Developments
Table 116. Pfizer Therapeutic Antibodies Drug Basic Information
Table 117. Pfizer Therapeutic Antibodies Drug Product Overview
Table 118. Pfizer Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Pfizer Business Overview
Table 120. Pfizer Recent Developments
Table 121. Regeneron Therapeutic Antibodies Drug Basic Information
Table 122. Regeneron Therapeutic Antibodies Drug Product Overview
Table 123. Regeneron Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Regeneron Business Overview
Table 125. Regeneron Recent Developments
Table 126. Innovent Therapeutic Antibodies Drug Basic Information
Table 127. Innovent Therapeutic Antibodies Drug Product Overview
Table 128. Innovent Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Innovent Business Overview
Table 130. Innovent Recent Developments
Table 131. Hengrui Medicine Therapeutic Antibodies Drug Basic Information
Table 132. Hengrui Medicine Therapeutic Antibodies Drug Product Overview
Table 133. Hengrui Medicine Therapeutic Antibodies Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Hengrui Medicine Business Overview
Table 135. Hengrui Medicine Recent Developments
Table 136. Global Therapeutic Antibodies Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Therapeutic Antibodies Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Therapeutic Antibodies Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Therapeutic Antibodies Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Therapeutic Antibodies Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Therapeutic Antibodies Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Therapeutic Antibodies Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Therapeutic Antibodies Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Therapeutic Antibodies Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Therapeutic Antibodies Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Therapeutic Antibodies Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Therapeutic Antibodies Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Therapeutic Antibodies Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Therapeutic Antibodies Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Therapeutic Antibodies Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Therapeutic Antibodies Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Therapeutic Antibodies Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Therapeutic Antibodies Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Therapeutic Antibodies Drug Market Size (M USD), 2019-2030
Figure 5. Global Therapeutic Antibodies Drug Market Size (M USD) (2019-2030)
Figure 6. Global Therapeutic Antibodies Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Therapeutic Antibodies Drug Market Size by Country (M USD)
Figure 11. Therapeutic Antibodies Drug Sales Share by Manufacturers in 2023
Figure 12. Global Therapeutic Antibodies Drug Revenue Share by Manufacturers in 2023
Figure 13. Therapeutic Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Therapeutic Antibodies Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Therapeutic Antibodies Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Therapeutic Antibodies Drug Market Share by Type
Figure 18. Sales Market Share of Therapeutic Antibodies Drug by Type (2019-2024)
Figure 19. Sales Market Share of Therapeutic Antibodies Drug by Type in 2023
Figure 20. Market Size Share of Therapeutic Antibodies Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Therapeutic Antibodies Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Therapeutic Antibodies Drug Market Share by Application
Figure 24. Global Therapeutic Antibodies Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Therapeutic Antibodies Drug Sales Market Share by Application in 2023
Figure 26. Global Therapeutic Antibodies Drug Market Share by Application (2019-2024)
Figure 27. Global Therapeutic Antibodies Drug Market Share by Application in 2023
Figure 28. Global Therapeutic Antibodies Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Therapeutic Antibodies Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Therapeutic Antibodies Drug Sales Market Share by Country in 2023
Figure 32. U.S. Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Therapeutic Antibodies Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Therapeutic Antibodies Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Therapeutic Antibodies Drug Sales Market Share by Country in 2023
Figure 37. Germany Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Therapeutic Antibodies Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Therapeutic Antibodies Drug Sales Market Share by Region in 2023
Figure 44. China Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Therapeutic Antibodies Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Therapeutic Antibodies Drug Sales Market Share by Country in 2023
Figure 51. Brazil Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Therapeutic Antibodies Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Therapeutic Antibodies Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Therapeutic Antibodies Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Therapeutic Antibodies Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Therapeutic Antibodies Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Therapeutic Antibodies Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Therapeutic Antibodies Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Therapeutic Antibodies Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Therapeutic Antibodies Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Therapeutic Antibodies Drug Market Size (M USD), 2019-2030
Figure 5. Global Therapeutic Antibodies Drug Market Size (M USD) (2019-2030)
Figure 6. Global Therapeutic Antibodies Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Therapeutic Antibodies Drug Market Size by Country (M USD)
Figure 11. Therapeutic Antibodies Drug Sales Share by Manufacturers in 2023
Figure 12. Global Therapeutic Antibodies Drug Revenue Share by Manufacturers in 2023
Figure 13. Therapeutic Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Therapeutic Antibodies Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Therapeutic Antibodies Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Therapeutic Antibodies Drug Market Share by Type
Figure 18. Sales Market Share of Therapeutic Antibodies Drug by Type (2019-2024)
Figure 19. Sales Market Share of Therapeutic Antibodies Drug by Type in 2023
Figure 20. Market Size Share of Therapeutic Antibodies Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Therapeutic Antibodies Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Therapeutic Antibodies Drug Market Share by Application
Figure 24. Global Therapeutic Antibodies Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Therapeutic Antibodies Drug Sales Market Share by Application in 2023
Figure 26. Global Therapeutic Antibodies Drug Market Share by Application (2019-2024)
Figure 27. Global Therapeutic Antibodies Drug Market Share by Application in 2023
Figure 28. Global Therapeutic Antibodies Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Therapeutic Antibodies Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Therapeutic Antibodies Drug Sales Market Share by Country in 2023
Figure 32. U.S. Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Therapeutic Antibodies Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Therapeutic Antibodies Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Therapeutic Antibodies Drug Sales Market Share by Country in 2023
Figure 37. Germany Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Therapeutic Antibodies Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Therapeutic Antibodies Drug Sales Market Share by Region in 2023
Figure 44. China Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Therapeutic Antibodies Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Therapeutic Antibodies Drug Sales Market Share by Country in 2023
Figure 51. Brazil Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Therapeutic Antibodies Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Therapeutic Antibodies Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Therapeutic Antibodies Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Therapeutic Antibodies Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Therapeutic Antibodies Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Therapeutic Antibodies Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Therapeutic Antibodies Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Therapeutic Antibodies Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Therapeutic Antibodies Drug Market Share Forecast by Application (2025-2030)
